Recently, the expression of MALAT1 has been a focus in our studies where the relationship between lncRNA MALAT1 and METTL3, a methyltransferase enzyme that catalyzes the N6-methyladenosine (m6A) modification, were described in the thymic carcinoma cell line, TC1889. The gene discussed is METTL3; the disease is thymic carcinoma.